By Douglas Johnson, MD, MSCI, Assistant Professor of Medicine & Clinical Director, Melanoma, Vanderbilt-Ingram Cancer Center  |  May 31, 2017

Profiling Melanoma to Predict Immune Therapy Success

May is Melanoma awareness month, and our series on melanoma continues with a discussion with Dr. Douglas B. Johnson of the Vanderbilt-Ingram Cancer Center. Dr. Johnson leads Vanderbilt’s melanoma clinical and research program, overseeing clinical trials, patient care and translational research. His research interests focus on developing new immune and…more.

By Keith Flaherty, MD, President, Society for Melanoma Research  |  May 24, 2017

Accelerating Melanoma Research

It’s Melanoma Awareness Month and this week, Real World Health Care is pleased to shine a light on The Society for Melanoma Research. We spoke with the Society’s President, Keith Flaherty, MD. In addition to his role with SMR, Dr. Flaherty serves as director of the Henri & Belinda Termeer…more.

Categories: General, Melanoma
By Emily Burke, Ph.D., Director of Instruction, BiotechPrimer.com  |  May 9, 2017

The Mechanics of Melanoma

May is Melanoma Awareness Month. This article originally appeared in the Biotech Primer WEEKLY. For more on the science behind the headlines, subscribe.  Melanoma 101  Melanoma accounts for less than one percent of skin cancer cases, yet accounts for the vast majority of skin cancer deaths (skincancer.org). If detected early…more.

Categories: General, Melanoma
By Erica Carpenter, MBA, PhD, Perelman School of Medicine, University of Pennsylvania  |  Dec 14, 2016

NSCLC: The Emerging Role of Liquid Biopsies

Real World Health Care concludes its series on non-small cell lung cancer by speaking with Erica Carpenter, MBA, PhD, Research Assistant Professor in the Department of Medicine at the Perelman School of Medicine at the University of Pennsylvania. Dr. Carpenter also serves as Director of the Circulating Tumor Material Laboratory…more.

By Lecia Sequist, MD, MPH, Associate Professor of Medicine, Harvard Medical School  |  Dec 7, 2016

Non-Small Cell Lung Cancer: EGFR Mutations and Targeted Therapies

Continuing our series on non-small cell lung cancer, this week Real World Health Care speaks with Lecia V. Sequist, MD, MPH, Associate Professor of Medicine at Harvard Medical School and the Mary B. Soltonstall endowed chair in oncology at Massachusetts General Hospital. Dr. Sequist’s research focuses on studying novel targets…more.

By Edward Garon, MD, Associate Professor of Medicine, David Geffen School of Medicine, UCLA Health  |  Nov 30, 2016

NSCLC: Targeting What Drives People’s Cancer

This week, Real World Health Care talks with Edward B. Garon, M.D., Associate Professor of Medicine at the David Geffen School of Medicine at UCLA Health. He specializes in hematology and oncology, with an interest in lung cancer and chest malignancies. Dr. Garon’s research focuses on the testing and development…more.

By Hossein Borghaei, DO, Fox Chase Cancer Center  |  Nov 16, 2016

NSCLC: The Promise of Immunotherapy

As part of our series on non-small cell lung cancer (NSCLC), Real World Health Care spoke with Hossein Borghaei, D.O., in the Department of Hematology/Oncology at Fox Chase Cancer Center, which is part of the Temple Health System. Dr. Borghaei serves as Chief, Thoracic Medical Oncology; Director, Lung Cancer Risk…more.

By Gregory Masters, MD, FASCO, Associate Professor, Thomas Jefferson University Medical School  |  Nov 2, 2016

Non-Small Cell Lung Cancer: With Greater Understanding Comes Greater Challenges

This week, Real World Health Care speaks with lung cancer specialist, Gregory Masters, MD, FASCO, attending physician at the Helen F. Graham Cancer Center and associate professor at the Thomas Jefferson University Medical School. In addition to being Fellow of the American Society for Clinical Oncology, Dr. Masters is co-chair…more.

By Susan Rappaport, MPH, Vice President for Research and Scientific Affairs, American Lung Association  |  Oct 19, 2016

American Lung Association: Research Focused on Improving Patient Care and Saving Lives

As part of our series on non-small cell lung cancer (NSCLC), Real World Health Care spoke with Susan J. Rappaport, MPH, vice president for research and scientific affairs, American Lung Association. Rappaport provides leadership and direction in the development and implementation of the American Lung Association public health education and…more.

By Jennifer King, PhD, Director of Science and Research, Lung Cancer Alliance  |  Oct 5, 2016

Lung Cancer Alliance Moves Research Forward Through Innovative Partnerships

This week, Real World Health Care speaks with Jennifer King, Ph.D., Director of Science and Research for the Lung Cancer Alliance. The Lung Cancer Alliance is the leading and highest rated nonprofit organization dedicated to fighting lung cancer in the nation. Since 1995, it has played a critical role in…more.

Close menu